Photodynamic therapy (PDT) treatment planning is on the verge of entering the age of precision and personalized medicine replacing the current empirical treatment protocols.
CCRM turns 10: What does this mean for cell and gene therapy in Canada? newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.
Dr. Lou Siminovitch, the force behind early genetics research in Canada, dies at age 100 cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.
Date Time
In memoriam: Louis Siminovitch, father of genetic research in Canada Louis Siminovitch was the first chair of what is now U of T’s department of molecular genetics and the founding director of Sinai Health’s Lunenfeld-Tanenbaum Research Institute (photo by Dave Chan/Sinai Health Foundation)
The University of Toronto community is remembering University Professor Louis Siminovitch, a scientific visionary who was the first chair of what is today the department of molecular genetics in the Temerty Faculty of Medicine.
Siminovitch, who was also the founding director of the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health, died this week nearly one year after celebrating his 100th birthday, which took place as COVID-19 forced the world to physically distance and scientists stepped up to confront the challenge of a lethal new virus.